The global medical device market, currently valued at approximately $6.8 trillion, is expanding at a steady clip, with analysts projecting sustained growth driven by technological advances, rising clinical demand, and aging populations worldwide.
According to a recent KPMG analysis, the sector’s global annual sales are expected to grow at a compound annual growth rate of 5.2% from 2023 onward, reaching $758.9 billion by 2030. Some projections suggest the market could surpass $1.1 trillion by 2034.
This robust growth trajectory is drawing investor attention to medical device stocks and related exchange-traded funds (ETFs).
In its 2024 outlook on technology and artificial intelligence in healthcare, KPMG highlighted rapid innovation in diabetes care, cardiology, robotic surgery, internet-connected wearables, and AI-enabled devices as major factors exciting both providers and investors.
The World Health Organization estimates there are currently around 2 million different types of medical devices available—from neurostimulators and surgical implants to ultrasound systems, robotic technologies, and insulin delivery systems. Continuous innovation continues to broaden the sector’s boundaries.
Several global medical device leaders are well-placed to capture this growth:
For those seeking broader sector exposure, several ETFs offer access to a basket of medical device companies:
| ETF Name | Issuer | Expense Ratio | Key Holdings/Strategy |
| iShares U.S. Medical Devices ETF | BlackRock | 0.40% | U.S.-focused; holds Abbott, Intuitive Surgical |
| SPDR S&P Health Care Equipment ETF | State Street | 0.35% | Medical device and supply companies |
| First Trust Indxx Medical Equipment ETF | First Trust | 0.70% | Global medical device firms |
Supported by technological breakthroughs, unmet clinical needs, and an aging global population, the medical device industry appears poised for durable long-term growth. Both equity and ETF investors are likely to keep a close watch on this dynamic sector.
